Arvinas, Inc. (ARVN) Earnings History
Annual and quarterly earnings data from 2016 to 2025
Loading earnings history...
EPS Growth Rates (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | -151.8% | -45.1% | -30.8% |
| 2024 | 100.0% | -95.0% | -75.5% |
| 2023 | 100.0% | -511.5% | -467.9% |
| 2022 | 100.0% | -200.3% | -215.0% |
| 2021 | 100.0% | -351.5% | -356.3% |
Download Data
Export ARVN earnings history in CSV or JSON format
Free sign-in required to download data
Arvinas, Inc. (ARVN) Earnings Overview
As of February 28, 2026, Arvinas, Inc. (ARVN) reported trailing twelve-month net income of -$81M, reflecting +0.5% year-over-year growth. The company earned $-1.25 per diluted share over the past four quarters, with a net profit margin of -0.3%.
Looking at the long-term picture, ARVN's historical earnings data spans multiple years. The company achieved its highest annual net income of -$14M in fiscal 2016.
Arvinas, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to industry peers including REGN ($4.50B net income, 0.3% margin), CNTA (-$243M net income), IMNM (-$223M net income, -32.4% margin), ARVN has room to improve margins relative to the peer group. Compare ARVN vs REGN →
Peer Comparison
Earnings metrics vs industry competitors
Historical Data
10 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$81M | +59.4% | -$119M | $-1.28 | -30.8% | -45.1% |
| 2024 | -$199M | +45.8% | -$250M | $-2.77 | -75.5% | -95.0% |
| 2023 | -$367M | -30.0% | -$402M | $-6.62 | -467.9% | -511.5% |
| 2022 | -$283M | -47.9% | -$263M | $-5.31 | -215.0% | -200.3% |
| 2021 | -$191M | -60.1% | -$188M | $-3.82 | -356.3% | -351.5% |
| 2020 | -$119M | -69.7% | -$121M | $-3.02 | -460.6% | -466.4% |
| 2019 | -$70M | -69.5% | -$52M | $-1.89 | -163.6% | -119.9% |
| 2018 | -$41M | -72.5% | -$44M | $-1.31 | -289.6% | -305.8% |
| 2017 | -$24M | -67.6% | -$25M | $-1.38 | -317.3% | -326.7% |
| 2016 | -$14M | - | -$16M | $-7.56 | -215.2% | -247.0% |
See ARVN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ARVN Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare ARVN vs AGIO
See how ARVN stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
Is ARVN growing earnings?
ARVN EPS of $-1.25 reflects slowing growth at +0.5%, below the 5-year CAGR of N/A. TTM net income is $-81M. Expansion rate has moderated.
What are ARVN's profit margins?
Arvinas, Inc. net margin is -0.3%, with operating margin at -0.5%. Below-average margins reflect competitive or cost pressures.
How consistent are ARVN's earnings?
ARVN earnings data spans 2016-2025. The current earnings trend is +0.5% YoY. Historical data enables comparison across business cycles.